Takeda Calls $2.2B Actos Settlement Report 'Rumor'
By Sindhu Sundar ( April 2, 2015, 6:30 PM EDT) -- Takeda Pharmaceutical Co. on Thursday appeared to dismiss as "marketplace rumors" news reports claiming the drugmaker plans to pay $2.2 billion to settle thousands of federal and state suits over the alleged cancer risks of its diabetes drug Actos....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.